Search research articles
Contact Us
Filters
Showing results (41-50 of 203) with videos related to
Page
of 21
Sort By:
Gynecologic Oncology
|
April 10, 2017
Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers
Laura J Havrilesky, Haley A Moss, Junzo Chino, et al.
JAMA Oncology
|
December 10, 2017
Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Haley A Moss, Andrew Berchuck, Megan L Neely, et al.
Obstetrics and Gynecology
|
December 21, 2023
Estimated National Cost of Pelvic Organ Prolapse Surgery in the United States
Brad St Martin, Melissa A Markowitz, Evan R Myers, et al.
Cancer
|
November 7, 2003
Decision science and cervical cancer
Scott B Cantor, Marianne C Fahs, Jeanne S Mandelblatt, et al.
American Heart Journal
|
May 22, 2012
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization
Matthew J Crowley, Benjamin J Powers, Evan R Myers, et al.
American Journal of Perinatology
|
August 22, 2018
Induction of Labor versus Scheduled Cesarean in Morbidly Obese Women: A Cost-Effectiveness Analysis
Maeve K Hopkins, Chad A Grotegut, Geeta K Swamy, et al.
Gynecologic Oncology
|
June 15, 2015
Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention
Joseph A Dottino, William A Cliby, Evan R Myers, et al.
Obstetrics and Gynecology
|
December 2, 2005
The FIBROID Registry: symptom and quality-of-life status 1 year after therapy
James B Spies, Evan R Myers, Robert Worthington-Kirsch, et al.
The Journal of Urology
|
October 20, 2009
Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence
Nazema Y Siddiqui, Cindy L Amundsen, Anthony G Visco, et al.
American Journal of Obstetrics and Gynecology
|
November 1, 2011
Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends
Mary Ellen Wechter, Elizabeth A Stewart, Evan R Myers, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 203) with videos related to
Sort By:
Page
of 21
Gynecologic Oncology
|
April 10, 2017
Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers
Laura J Havrilesky, Haley A Moss, Junzo Chino, et al.
JAMA Oncology
|
December 10, 2017
Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Haley A Moss, Andrew Berchuck, Megan L Neely, et al.
Obstetrics and Gynecology
|
December 21, 2023
Estimated National Cost of Pelvic Organ Prolapse Surgery in the United States
Brad St Martin, Melissa A Markowitz, Evan R Myers, et al.
Cancer
|
November 7, 2003
Decision science and cervical cancer
Scott B Cantor, Marianne C Fahs, Jeanne S Mandelblatt, et al.
American Heart Journal
|
May 22, 2012
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization
Matthew J Crowley, Benjamin J Powers, Evan R Myers, et al.
American Journal of Perinatology
|
August 22, 2018
Induction of Labor versus Scheduled Cesarean in Morbidly Obese Women: A Cost-Effectiveness Analysis
Maeve K Hopkins, Chad A Grotegut, Geeta K Swamy, et al.
Gynecologic Oncology
|
June 15, 2015
Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention
Joseph A Dottino, William A Cliby, Evan R Myers, et al.
Obstetrics and Gynecology
|
December 2, 2005
The FIBROID Registry: symptom and quality-of-life status 1 year after therapy
James B Spies, Evan R Myers, Robert Worthington-Kirsch, et al.
The Journal of Urology
|
October 20, 2009
Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence
Nazema Y Siddiqui, Cindy L Amundsen, Anthony G Visco, et al.
American Journal of Obstetrics and Gynecology
|
November 1, 2011
Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends
Mary Ellen Wechter, Elizabeth A Stewart, Evan R Myers, et al.
Page
of 21